BioSig Technologies, Inc. announces a proposed public offering of common stock or pre-funded warrants.
The offering is underwritten and subject to market conditions.
Net proceeds will be used for purchasing gold bullion, working capital, and general corporate purposes.
Offer Details
The offering includes shares of common stock or pre-funded warrants.
Underwriters
Clear Street and Needham & Company are acting as joint book-running managers.
SEC Registration
The offering is made under a shelf registration statement on Form S-3 (File No. 333-276298).
Prospectus Information
Interested parties should read the preliminary prospectus supplement and accompanying base prospectus.
- The offering aims to raise funds for specific purposes like gold bullion purchase and working capital.
- The joint book-running managers play a crucial role in facilitating the offering.
BioSig Technologies Inc.'s proposed public offering signifies a strategic move to raise capital for essential purposes, reflecting confidence in its investment policy and future growth opportunities.